AvoMD secures $10M Series A from U.S. investors, led by Noro-Moseley Partners, for its EHR-integrated clinical AI platform 'Avo'.

AvoMD secures $10M Series A from U.S. investors, led by Noro-Moseley Partners, for its EHR-integrated clinical AI platform 'Avo'.

AvoMD, founded by CEO Dr. Joongheum Park, a practicing hospitalist at Harvard-affiliated BIDMC, has raised a $10 million Series A round. The investment was led by Noro-Moseley Partners, with participation from existing investors like AlleyCorp, Las Olas Ventures, MedMountain Ventures, and Epsilon Health Investors, plus new investor Scrub Capital. Domestic Korean investors include Dunamu & Partners, Mirae Asset Capital, and FuturePlay. The capital will fuel the company's push into the U.S. healthcare market with its platform that integrates directly with major EHR systems like Epic, athenahealth, and MEDITECH.

This funding underscores the strategic and technical pivot in healthcare AI towards deeply integrated, workflow-native solutions rather than standalone diagnostic tools. AvoMD's approach of embedding AI directly into the clinician's EHR workflow to combine patient data, evidence-based guidelines, hospital protocols, and billing policies in a single stream addresses a critical adoption barrier: clinician burden and system interoperability. The participation of specialized U.S. healthcare and health-tech VCs validates the model's potential to drive tangible operational efficiencies and revenue cycle improvements within the complex U.S. healthcare system, a key battleground for enterprise AI.

A grounded expert take recognizes the significance of a practicing physician-founder tackling a genuine workflow pain point. The reported results—35% reduction in charting time per patient, $11.6M in savings for a multi-national outpatient group, and a $7.5M annual increase in billed revenue for an academic medical center—are the precise metrics (efficiency, cost, revenue) that drive enterprise sales in healthcare. The recent partnership with EBSCO Clinical Decisions to integrate its point-of-care guidelines further strengthens the platform's value proposition as a centralized clinical hub. The challenge remains scaling across diverse health systems with varying EHR configurations and clinical cultures, but this funding provides robust validation and fuel for that execution phase.

#HealthcareAI #ClinicalWorkflow #EHRIntegration #DigitalHealth #VentureCapital #AvoMD